AstraZeneca has become the latest big pharma company to devote new cash to its US manufacturing muscle this year as it ...
AstraZeneca’s earnings were boosted by its oncology, cardiovascular, respiratory and immunology (R&I), and rare disease ...
Concerns over AZ’s large China business escalated in the past few days after word came out that the company’s China president ...
AstraZeneca Plc is increasingly looking to the US for growth as its once fast-expanding China business faces challenges amid ...
AstraZeneca said on Wednesday its China president Leon Wang had been detained by Chinese authorities and, although it did not ...
However, performance was overshadowed by legal issues in China. The group revealed last week that Leon Wang, its China ...
AstraZeneca PLC aims for $80 billion revenue by 2030 through strong growth in oncology, biopharmaceuticals, and rare diseases ...
Leon Wang, executive vice president in charge of China and the broader Asian region, is being detained while the Chinese ...
AstraZeneca chief Pascal Soriot has said a deepening criminal probe into his company’s Chinese business is being taken “very ...